Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titlets.xpt (trial summary, study level parameters)
  • Assumption: The intent of this dataset is to provide a summary of trial (study) information. This is not subject-level data. 
  • Assumption: A Trial (study) can have more than one assay type
  • Assumption: ASSAYID value of ALL indicates that it applies to all assays in the study
  • BLEO & CPA - are positive controls, should this be included/where is this captured? — in results for the record / row?
MNvitOECD Test 487 MNvit

Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123ALLNRUTS1
GLPTYPGood Laboratory Practice TypeFDA
2123ALLNRUTS2
GLPTYPGood Laboratory Practice TypeOECD
3123ALLNRUTS1
STSTDTCStudy Start Date2022-05-25
4123ALLNRUTS1
STITLEStudy Title

Determination of the in vitro genotoxicity potential of 10 tobacco products in both the in vitro Micronucleus Assay and the in vitro Neutral Red Uptake


5123ALLNRUTS1
SNDIGVERSEND Implementation Guide VersionTOBACCO IMPLEMENTATION GUIDE VERSION 1.0
6123ALLNRUTS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-09-30
7123ALLNRUTS1
SSPONSORSponsor OrganizationExample Sponsor Inc.
8123ALLNRUTS1
SPREFIDSponsor's Study Reference ID
NOT APPLICABLE
9123ALLNRUTS11TSTFNAMTest Facility NameExample Tox Lab Name
10123ALLNRUTS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
11123ALLNRUTS11TFCNTRYTest Facility CountryUSA
...12123ALLNRUTS11STDIRStudy DirectorDr. R. Smith
13123ALLNRUTS1
GLPFLGLP FlagY
14123NRUTS1
ASTDAssay StandardNIH Publication No. 07-4519
15123NRUTS1
ASTDVAssay Standard Version2016-07-29123MNvitTS1SSTYPStudy TypeGENOTOXICITY IN VITRO123MNvitTS1SSSTYPStudy Sub TypeIn Vitro Micronucleus123MNvitTS1SPECIESSpeciesHomo Sapiens123MNvitTS1??Test System?TK6 Lymphoblastoid Suspension Cells2006-11
16123NRU123NRUTS1ASTDAssay StandardNIH Publication No. 07-4519123NRUTS1ASTDVAssay Standard Version2006-11123NRUTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
17123NRUTS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red Uptake
18123NRUTS1
SPECIESSpeciesSalmonella enterica 
19123NRUTS1
??Test System??Normal Human Keratinocyte
1
Expand
titletx.xpt (trial sets)
  • During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled;  For now, we just include good example values based on our experience
  • Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations as specified in the trial design.
  • BLEO & CPA - are positive controls, should this be included/where is this captured? — in results for the record / row?
  • Where is TK6 cell type?  is this test system (see below)
    • needs to be allowed to vary down to the well level / result level
RowSTUDYIDASSAYIDDOMAINSETCD
SET (what sponsor calls it)
TXSEQTXPARMCDTXPARMTXVAL
1123NRUTX1-1-A
(plate-col-row in the 96-well plate)
CSC-10
(through SLS-200)

PLATENUM. (e.g., 1 or 2)
1
2123NRUTX1-1-ACSC-10
WELLNUM (e.g., 1-A through 10-H)
Number representing the location of the well in the 96-well plate1-A 
3123NRUTX1-1-ACSC-10
INTRVNname of the intervention articleCigarette Smoke Condensate
4123NRUTX1-1-ACSC-10
ITVTYPE
(CT e.g, Product, positive control, negative control)
type of intervention articlePRODUCT
5123NRUTX1-1-ACSC-10
ITVCONCintervention concentration10
6123NRUTX1-1-ACSC-10
ITVCONCUintervention unitug/ml
7123NRUTX1-1-ACSC-10
STRAINStrain/SubstrainSalmonella enterica enterica
8123NRUTX1-1-ACSC-10
REGIMESmoking RegimeTraditional combustible 
9123
NRUTX1-1-ACSC-10
NRU

RUN

Assay run number (how is this different from REPNUM)

1

10

123NRUTX1-1-ACSC-10
PORTPort ID1
11123NRUTX1-1-ACSC-10
SMPLIDSample ID030001
12123NRUTX1-1-ACSC-10
SMKFRCSmoke FractionA
13123NRUTX1-1-ACSC-10
REPNUMReplicate Number1
11
14123NRUTX1-1-BCSC-10
ITVCONCintervention concentration10
12
15123NRUTX1-1-BCSC-10
ITVCONCUintervention unitug/ml
...


...





123NRUTX1-10-HSLS-10
PLATENUMPlate number1  

123NRUTX1-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate10-H

123NRUTX1-10-HSLS-10
INTRVNname of the intervention articlesodium laurel sulfate

123NRUTX1-10-HSLS-10
ITVTYPEtype of intervention articlePOSITIVE CONTROL

123NRUTX1-10-HSLS-10
ITVCONCintervention concentration200

123NRUTX1-10-HSLS-10
ITVCONCUintervention unitug/ml
...


...





123NRUTX2-10-HSLS-10
PLATENUMPlate number2

123NRUTX2-10-HSLS-10
WELLNUMNumber representing the location of the well in the 96-well plate10-H

123NRUTX2-10-HSLS-10
INTRVNname of the intervention articlesodium laurel sulfate

123NRUTX2-10-HSLS-10
ITVTYPEtype of intervention articlePOSITIVE CONTROL

123NRUTX2-10-HSLS-10
ITVCONCintervention concentration200

123NRUTX2-10-HSLS-10
ITVCONCUintervention unitug/ml
Expand
titlegt.xpt (similar to LB)

RowSTUDYIDASSAYIDDOMAINTXCDGTSEQGTTESTCDGTTESTGTORRESGTORRESUGTSTRESCGTSTRESNGTSTRESU
1123NRUGT1-1-A1RELABSRelative Absorbance Reading100ug/ml100100ug/ml
2123NRUGT1-1-B1RELABSRelative Absorbance Reading107ug/ml100100ug/ml
3123NRUGT1-1-C1RELABSRelative Absorbance Reading98.6ug/ml100100ug/ml
4123NRUGT1-1-D1RELABSRelative Absorbance Reading94.9ug/ml100100ug/ml
5123NRUGT1-1-E1RELABSRelative Absorbance Reading111ug/ml111111ug/ml

123NRUGT1-1-F1RELABSRelative Absorbance Reading96.9ug/ml96.996.9ug/ml

123NRUGT1-1-G1RELABSRelative Absorbance Reading105ug/ml105105ug/ml

123NRUGT1-1-H1RELABSRelative Absorbance Reading95.2ug/ml95.295.2ug/ml
10123NRUGT1-2-A1RELABSRelative Absorbance Reading

83.0

ug/ml83.083.0ug/ml
11123NRUGT1-2-B1RELABSRelative Absorbance Reading77.7

ug/ml

77.777.7ug/ml
...


...







80123NRUGT1-10-H1RELABSRelative Absorbance Reading0.791ug/ml0.7910.791ug/ml
...


...







160123NRUGT2-10-H1RELABSRelative Absorbance Reading0.780ug/ml0.7800.780ug/ml